Bioteque Corporation (TPEX:4107)

Market Cap	8.00B -6.9%
Revenue (ttm)	2.16B +3.3%
Net Income	549.63M +2.3%
EPS	7.89 +2.3%
Shares Out	69.30M
PE Ratio	14.64
Forward PE	n/a
Dividend	5.50 (4.76%)
Ex-Dividend Date	Jul 28, 2026

Volume	65,703
Open	116.50
Previous Close	116.50
Day's Range	115.50 - 117.00
52-Week Range	109.50 - 132.00
Beta	0.14
Analysts	Hold
Price Target	121.00 (+4.76%)
Earnings Date	Aug 12, 2026

About Bioteque

Bioteque Corporation manufactures and sells medical devices in Asia, South America, North America, and internationally. The company offers angiography catheter, balloon dilation catheter, guiding sheath, guide steel wire, y-type connector, multi-pipe joint, connecting pipe, y-type connector assembly, peripheral vascular guiding catheter, coronary balloon dilation catheter, central venous catheter, microcatheter assembly, injection tube sleeve assembly for radiographic catheters, micro-puncture guide assembly, closed suction catheter, oxygen mas...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1991
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4107

Financial Performance

In 2025, Bioteque's revenue was 2.14 billion, an increase of 3.03% compared to the previous year's 2.07 billion. Earnings were 539.19 million, an increase of 2.07%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 19, 2026

Data Sources Report a data error